Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia A Moore

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nature|April 7, 2012
Media centre: vital to US scienceJulia A Moore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapyPhuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nature|April 7, 2012
Media centre: vital to US scienceJulia A Moore
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapyPhuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Pageof 1